City Vets is Celebrating Our One Year Anniversary and Has Two Exciting Announcements!

    NEXT STORY
    Spero Reports Preliminary Findings from Phase 1 Clinical Trial of SPR720 and Announces Plans to Advance Program into Proof-of-Concept Clinical Trial in Patients with NTM Pulmonary Disease
    PREV STORY
    Analysis on the World Market for Biomarkers 2016-2019 & 2025: Key Trends, Discovery Techniques & Applications
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Editas Medicine Announces Chief Executive Officer Transition

    Katrine Bosley to Step Down as President and CEO Director Cynthia Collins to Serve ...

    author_avatar
    NASDAQ Market News

    Deciphera Pharmaceuticals, Inc. and Zai Lab Limited Announce an Exclusive License Agreement for Ripretinib in Greater China

    author_avatar
    NASDAQ Market News

    G1 Therapeutics to Present Phase 1b Data on G1T38 in Combination with Faslodex for Treatment of Breast Cancer at 2018 American Society of Clinical Oncology (ASCO) Annual Meeting

    RESEARCH TRIANGLE PARK, N.C., May 16, 2018 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq:GTHX), ...

    author_avatar
    NASDAQ Market News